EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Strain-level genetic heterogeneity and colonization dynamics drive microbiome therapeutic efficacy

Kai Chen, Yina Liu, Jie Rong, Ningbin Dai, Caihua Xu, Heng Li, Ling Zhong, Baoyan Wang, Zhen Ji, Shichang Xie, Yangzuo Xu, Fulin Yang und 14 weitere

Cell Host & Microbe · 2026-03 · 34 (3) · 393-405.e5

DOI: 10.1016/j.chom.2026.02.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Host & Microbe, 2026-03. Verfasst von Kai Chen und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The First Affiliated Hospital of Soochow University, Cancer Institute, Suzhou Medical College, Soochow University, Suzhou, Su…. Hauptthemen laut MEDLINE: Fecal Microbiota Transplantation, Genetic Heterogeneity, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shenzhen Basic Research Program, Jiangsu Province Science and Technology Bureau, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fecal microbiota transplantation (FMT) has shown immunotherapeutic promise, yet its efficacy in non-small-cell lung cancer (NSCLC) remains unclear. We demonstrate that FMT improves anti-PD-1 efficacy and progression-free survival in a single-arm trial of advanced PD-L1-negative NSCLC. Analyzing over 2,000 metagenomes from diverse disease cohorts and healthy controls via a high-resolution strain-tracking framework, we reveal that phylogenetically distinct strains within identical species exert opposing therapeutic effects, resolving prior inconsistencies. We identify conserved ecological principles where engraftment relies on species-intrinsic metabolic and immune evasion traits. Crucially, successful colonization by specific beneficial strain variants correlates with positive clinical outcomes. Finally, we identify 38 priority species with robust engraftment potential and significant heterogeneity as candidates for precision therapeutics. These findings establish a strain-function-efficacy paradigm, elucidating the mechanistic basis of variable outcomes and guiding next-generation microbiome drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fecal Microbiota TransplantationGenetic HeterogeneityCarcinoma, Non-Small-Cell LungLung NeoplasmsMicrobiotaGastrointestinal MicrobiomeHumansMetagenomeTreatment OutcomeAnimalsBacteria

Stichwörter der Autor:innen

FMTHSIM scoreNSCLCfecal microbiota transplantationhealthy strain in microbiome scoreimmune therapynon-small-cell lung cancerstrain trackingucgMLST

Autor:innen und Institutionen

  • Department of Oncology, The First Affiliated Hospital of Soochow University, Cancer Institute, Suzhou Medical College, Soochow University, Suzhou, Suzhou 215127, China.
  • Suzhou Key Laboratory of Precision Medicine in Oncology, MOE Key Laboratory of Geriatric Diseases and Immunology, Cancer Institute, Suzhou Medical College, Soochow University, Suzhou, Suzhou 215127, China; National Cent…
  • Suzhou Key Laboratory of Pathogenic Microorganisms for New and Emerging Major Infectious Diseases, Suzhou Biobank, Suzhou Center for Disease Control and Prevention, Suzhou 215131, China.
  • Department of Microbiology, School of Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, Suzhou 215123, China.
  • Suzhou Health Information Center, Suzhou Health Commission, Suzhou 215006, China; Suzhou Healthcare Digital Intelligence Innovation Laboratory, Suzhou 215006, China.
  • Department of Oncology, Changshu Second People's Hospital, Suzhou 215500, China.

Förderung

  • Shenzhen Basic Research Program
  • Jiangsu Province Science and Technology Bureau
  • National Natural Science Foundation of China
  • Suzhou City Science and Technology Bureau

Zitieren

APA

Chen, K., Liu, Y., Rong, J., Dai, N., Xu, C., Li, H., Zhong, L., Wang, B., Ji, Z., Xie, S., Xu, Y., Yang, F., Wang, J., Li, D., Gu, Y., Zhou, X., Li, Y., Chen, M., Chen, Y., …, & Zhou, Z. (2026). Strain-level genetic heterogeneity and colonization dynamics drive microbiome therapeutic efficacy. Cell Host & Microbe, 34(3), 393-405.e5. https://doi.org/10.1016/j.chom.2026.02.002

Vancouver

Chen K, Liu Y, Rong J, Dai N, Xu C, Li H, et al. Strain-level genetic heterogeneity and colonization dynamics drive microbiome therapeutic efficacy. Cell Host & Microbe. 2026;34(3):393-405.e5. doi:10.1016/j.chom.2026.02.002

BibTeX
@article{Chen2026,
  author = {Chen, Kai and Liu, Yina and Rong, Jie and Dai, Ningbin and Xu, Caihua and Li, Heng and Zhong, Ling and Wang, Baoyan and Ji, Zhen and Xie, Shichang and Xu, Yangzuo and Yang, Fulin and Wang, Jing and Li, Dapeng and Gu, Yulan and Zhou, Xiumin and Li, Yan and Chen, Minbin and Chen, Yanan and Li, Wei and Tang, Zaixiang and Cai, Jun and Xu, Jiancheng and Xia, Shuting and Zhan, Qimin and Zhou, Zhemin},
  title = {Strain-level genetic heterogeneity and colonization dynamics drive microbiome therapeutic efficacy},
  journal = {Cell Host & Microbe},
  year = {2026},
  volume = {34},
  number = {3},
  pages = {393--405.e5},
  doi = {10.1016/j.chom.2026.02.002}
}
Kostenlos starten →